Skip to main content

Palliative Care in COPD

  • Chapter
  • First Online:
Palliative Care in Lung Disease

Part of the book series: Respiratory Medicine ((RM))

Abstract

People who live with chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States, have chronic and progressively debilitating dyspnea and systemic symptoms that reduce quality of life and result in high acute care utilization near the end of life. Despite recommendations to integrate specialist palliative care in COPD and the proven benefits of its early integration in the care of patients with advanced cancer, specialist palliative care is exceedingly rare in COPD and is not typically considered by pulmonary clinicians until a person is at the very end of life. Palliative care beyond its role at the very end of life has much to offer patients with COPD and their families earlier in the disease trajectory. This chapter calls for early integration of palliative care into routine practice for COPD. We explore broad care needs experienced by patients with COPD and their families, define barriers to proactive palliative care referral in COPD, describe feasible inter-professional models for palliative care integration in COPD, and propose an innovative strategy for early palliative care integration into routine COPD practice through the fusion of palliative care into the field of pulmonary medicine, i.e., a “pallipulm” approach.

“The best time to plant a tree was 20 years ago. The next best time is now.” – Chinese Proverb

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Biener AI, Decker SL, Rohde F. Prevalence and treatment of chronic obstructive pulmonary disease (COPD) in the United States. JAMA. 2019;322:602.

    Article  PubMed  Google Scholar 

  2. Han MK, Martinez CH, Au DH, Bourbeau J, Boyd CM, Branson R, Criner GJ, Kalhan R, Kallstrom TJ, King A, Krishnan JA, Lareau SC, Lee TA, Lindell K, Mannino DM, Martinez FJ, Meldrum C, Press VG, Thomashow B, Tycon L, Sullivan JL, Walsh J, Wilson KC, Wright J, Yawn B, Zueger PM, Bhatt SP, Dransfield MT. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. Lancet Respir Med. 2016;4:473–526.

    Article  PubMed  Google Scholar 

  3. Barnes PJ, Burney PG, Silverman EK, Celli BR, Vestbo J, Wedzicha JA, Wouters EF. Chronic obstructive pulmonary disease. Nat Rev Dis Primers. 2015;1:15076.

    Article  PubMed  Google Scholar 

  4. Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, Lopez Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53:1900164.

    Article  CAS  PubMed  Google Scholar 

  5. Young KA, Strand M, Ragland MF, Kinney GL, Austin EE, Regan EA, Lowe KE, Make BJ, Silverman EK, Crapo JD, Hokanson JE, Investigators CO. Pulmonary subtypes exhibit differential global initiative for chronic obstructive lung disease spirometry stage progression: The COPDGene(R) Study. Chronic Obstr Pulm Dis. 2019;6:414–29.

    PubMed  PubMed Central  Google Scholar 

  6. Croft JB, Lu H, Zhang X, Holt JB. Geographic accessibility of pulmonologists for adults with COPD: United States, 2013. Chest. 2016;150:544–53.

    Article  PubMed  Google Scholar 

  7. Iyer AS, Cross SH, Dransfield MT, Warraich HJ. Urban-rural disparities in deaths from chronic lower respiratory disease in the United States. Am J Respir Crit Care Med. 2020.

    Google Scholar 

  8. van Dijk M, Gan CT, Koster TD, Wijkstra PJ, Slebos DJ, Kerstjens HAM, van der Vaart H, Duiverman ML. Treatment of severe stable COPD: the multidimensional approach of treatable traits. ERJ Open Res. 2020;6:00322.

    PubMed  PubMed Central  Google Scholar 

  9. Yohannes AM, Dryden S, Casaburi R, Hanania NA. Long-term benefits of pulmonary rehabilitation in COPD patients: a 2-year follow-up study. Chest. 2020.

    Google Scholar 

  10. Lindenauer PK, Stefan MS, Pekow PS, Mazor KM, Priya A, Spitzer KA, Lagu TC, Pack QR, Pinto-Plata VM, ZuWallack R. Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among Medicare beneficiaries. JAMA. 2020;323:1813–23.

    Article  PubMed  Google Scholar 

  11. Amblas-Novellas J, Murray SA, Espaulella J, Martori JC, Oller R, Martinez-Munoz M, Molist N, Blay C, Gomez-Batiste X. Identifying patients with advanced chronic conditions for a progressive palliative care approach: a cross-sectional study of prognostic indicators related to end-of-life trajectories. BMJ Open. 2016;6:e012340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s.

    Article  CAS  PubMed  Google Scholar 

  13. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, Bourbeau J. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J. 2010;35:1022–30.

    Article  CAS  PubMed  Google Scholar 

  14. Schmidt SA, Johansen MB, Olsen M, Xu X, Parker JM, Molfino NA, Lash TL, Sorensen HT, Christiansen CF. The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study. BMJ Open. 2014;4:e006720.

    Article  PubMed  PubMed Central  Google Scholar 

  15. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132:1748–55.

    Article  PubMed  Google Scholar 

  16. Global Burden of Disease Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–22.

    Article  Google Scholar 

  17. Khakban A, Sin DD, FitzGerald JM, McManus BM, Ng R, Hollander Z, Sadatsafavi M. The projected epidemic of chronic obstructive pulmonary disease hospitalizations over the next 15 years. A population-based perspective. Am J Respir Crit Care Med. 2017;195:287–91.

    PubMed  Google Scholar 

  18. Iyer AS, Goodrich CA, Dransfield MT, Alam SS, Brown CJ, Landefeld CS, Bakitas MA, Brown JR. End-of-life spending and healthcare utilization among older adults with chronic obstructive pulmonary disease. Am J Med. 2020;133:817–824 e811.

    Article  PubMed  Google Scholar 

  19. Cross SH, Ely EW, Kavalieratos D, Tulsky JA, Warraich HJ. Place of death for individuals with chronic lung disease: trends and associated factors from 2003 to 2017 in the United States. Chest. 2020;158:670–80.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ahmadi Z, Lundstrom S, Janson C, Strang P, Emtner M, Currow DC, Ekstrom M. End-of-life care in oxygen-dependent COPD and cancer: a national population-based study. Eur Respir J. 2015;46:1190–3.

    Article  CAS  PubMed  Google Scholar 

  21. Jolley CJ, Luo YM, Steier J, Rafferty GF, Polkey MI, Moxham J. Neural respiratory drive and breathlessness in COPD. Eur Respir J. 2015;45:355–64.

    Article  PubMed  Google Scholar 

  22. Munari AB, Gulart AA, Dos Santos K, Venancio RS, Karloh M, Mayer AF. Modified Medical Research Council dyspnea scale in GOLD classification better reflects physical activities of daily living. Respir Care. 2018;63:77–85.

    Article  PubMed  Google Scholar 

  23. Vikjord SAA, Brumpton BM, Mai XM, Vanfleteren L, Langhammer A. The association of anxiety and depression with mortality in a COPD cohort. The HUNT study, Norway. Respir Med. 2020;171:106089.

    Article  PubMed  Google Scholar 

  24. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, Wang C, Bourbeau J. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178:913–20.

    Article  PubMed  Google Scholar 

  25. Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF, Investigators CO. Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - a cross sectional analysis of the COPDGene cohort. J Psychosom Res. 2019;118:18–26.

    Article  PubMed  Google Scholar 

  26. Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manag. 2009;38:115–23.

    Article  Google Scholar 

  27. Kouijzer M, Brusse-Keizer M, Bode C. COPD-related fatigue: impact on daily life and treatment opportunities from the patient's perspective. Respir Med. 2018;141:47–51.

    Article  PubMed  Google Scholar 

  28. Paddison JS, Effing TW, Quinn S, Frith PA. Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J. 2013;41:565–70.

    Article  PubMed  Google Scholar 

  29. Kapella MC, Larson JL, Patel MK, Covey MK, Berry JK. Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res. 2006;55:10–7.

    Article  PubMed  Google Scholar 

  30. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M. Writing Group for the European Working Group on Sarcopenia in Older P, the Extended Group for E. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.

    Article  PubMed  Google Scholar 

  31. Benz E, Trajanoska K, Lahousse L, Schoufour JD, Terzikhan N, De Roos E, de Jonge GB, Williams R, Franco OH, Brusselle G, Rivadeneira F. Sarcopenia in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2019;28

    Google Scholar 

  32. Sepulveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11:1164–76.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Cardiovascular health study collaborative research G. frailty in older adults: evidence for a phenotype. J Gerontol Series A Biol Sci Med Sci. 2001;56:M146–56.

    Article  CAS  Google Scholar 

  34. Lahousse L, Ziere G, Verlinden VJ, Zillikens MC, Uitterlinden AG, Rivadeneira F, Tiemeier H, Joos GF, Hofman A, Ikram MA, Franco OH, Brusselle GG, Stricker BH. Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci. 2016;71:689–95.

    Article  CAS  PubMed  Google Scholar 

  35. Kennedy CC, Novotny PJ, LeBrasseur NK, Wise RA, Sciurba FC, Benzo RP. Frailty and clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2019;16:217–24.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Iyer AS, Wells JM, Bhatt SP, Kirkpatrick DP, Sawyer P, Brown CJ, Allman RM, Bakitas MA, Dransfield MT. Life-space mobility and clinical outcomes in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:2731–8.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Iyer AS, Dionne-Odom JN, Ford SM, Crump Tims SL, Sockwell ED, Ivankova NV, Brown CJ, Tucker RO, Dransfield MT, Bakitas MA. A formative evaluation of patient and family caregiver perspectives on early palliative care in COPD across disease severity. Ann Am Thor Soc. 2019.

    Google Scholar 

  38. Reijnders T, Schuler M, Jelusic D, Troosters T, Janssens W, Schultz K, von Leupoldt A. The impact of loneliness on outcomes of pulmonary rehabilitation in patients with COPD. COPD. 2018;15:446–53.

    Article  PubMed  Google Scholar 

  39. Christakis NA, Iwashyna TJ. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med. 1998;158:2389–95.

    Article  CAS  PubMed  Google Scholar 

  40. Trivedi RB, Bryson CL, Udris E, Au DH. The influence of informal caregivers on adherence in COPD patients. Ann Behav Med. 2012;44:66–72.

    Article  PubMed  Google Scholar 

  41. Figueiredo D, Gabriel R, Jacome C, Cruz J, Marques A. Caring for relatives with chronic obstructive pulmonary disease: how does the disease severity impact on family carers? Aging Ment Health. 2014;18:385–93.

    Article  PubMed  Google Scholar 

  42. Strang S, Osmanovic M, Hallberg C, Strang P. Family Caregivers' heavy and overloaded burden in advanced chronic obstructive pulmonary disease. J Palliat Med. 2018;21:1768–72.

    Article  PubMed  Google Scholar 

  43. Gabriel R, Figueiredo D, Jacome C, Cruz J, Marques A. Day-to-day living with severe chronic obstructive pulmonary disease: towards a family-based approach to the illness impacts. Psychol Health. 2014;29:967–83.

    Article  PubMed  Google Scholar 

  44. Spiker M, Paulsen K, Mehta AK. Primary palliative care education in U.S. residencies and fellowships: a systematic review of program leadership perspectives. J Palliat Med. 2020;23:1392–9.

    Article  PubMed  Google Scholar 

  45. Munday D, Boyd K, Jeba J, Kimani K, Moine S, Grant L, Murray S. Defining primary palliative care for universal health coverage. Lancet. 2019;394:621–2.

    Article  PubMed  Google Scholar 

  46. Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33:1438–45.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Lloyd A, Kendall M, Starr JM, Murray SA. Physical, social, psychological and existential trajectories of loss and adaptation towards the end of life for older people living with frailty: a serial interview study. BMC Geriatr. 2016;16:176.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–42.

    Article  CAS  PubMed  Google Scholar 

  49. Bakitas M, Lyons KD, Hegel MT, Balan S, Barnett KN, Brokaw FC, Byock IR, Hull JG, Li Z, McKinstry E, Seville JL, Ahles TA. The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions. Palliat Support Care. 2009;7:75–86.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA. 2009;302:741–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Vranas KC, Lapidus JA, Ganzini L, Slatore CG, Sullivan DR. Association of Palliative Care use and setting with health-care utilization and quality of care at the end of life among patients with advanced lung cancer. Chest. 2020;158:2667–74.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Sullivan DR, Chan B, Lapidus JA, Ganzini L, Hansen L, Carney PA, Fromme EK, Marino M, Golden SE, Vranas KC, Slatore CG. Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the veterans health administration. JAMA Oncol. 2019;

    Google Scholar 

  53. Quinn KL, Shurrab M, Gitau K, Kavalieratos D, Isenberg SR, Stall NM, Stukel TA, Goldman R, Horn D, Cram P, Detsky AS, Bell CM. Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: a systematic review and meta-analysis. JAMA. 2020;324:1439–50.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Diop MS, Rudolph JL, Zimmerman KM, Richter MA, Skarf LM. Palliative care interventions for patients with heart failure: a systematic review and meta-analysis. J Palliat Med. 2017;20:84–92.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manag. 2007;33:238–46.

    Article  Google Scholar 

  56. Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, Levy M, Mularski RA, Osborne ML, Prendergast TJ, Rocker G, Sibbald WJ, Wilfond B, Yankaskas JR, Force ATSE-o-LCT. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177:912–27.

    Article  PubMed  Google Scholar 

  57. Rush B, Hertz P, Bond A, McDermid RC, Celi LA. Use of palliative care in patients with end-Stage COPD and receiving home oxygen: national trends and barriers to care in the United States. Chest. 2017;151:41–6.

    Article  PubMed  Google Scholar 

  58. Bhatt SP, Wells JM, Iyer AS, Kirkpatrick DP, Parekh TM, Leach LT, Anderson EM, Sanders JG, Nichols JK, Blackburn CC, Dransfield MT. Results of a medicare bundled payments for care improvement initiative for chronic obstructive pulmonary disease readmissions. Ann Am Thorac Soc. 2017;14:643–8.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Moens K, Higginson IJ, Harding R, Euro I. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manag. 2014;48:660–77.

    Article  Google Scholar 

  60. Lane T, Ramadurai D, Simonetti J. Public awareness and perceptions of palliative and comfort care. Am J Med. 2019;132:129–31.

    Article  PubMed  Google Scholar 

  61. Iyer AS, Dionne-Odom JN, Khateeb DM, O'Hare L, Tucker RO, Brown CJ, Dransfield MT, Bakitas MA. A qualitative study of pulmonary and palliative care clinician perspectives on early palliative care in chronic obstructive pulmonary disease. J Palliat Med. 2020;23:513–26.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Brien SB, Lewith GT, Thomas M. Patient coping strategies in COPD across disease severity and quality of life: a qualitative study. NPJ Prim Care Respir Med. 2016;26:16051.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Disler RT, Green A, Luckett T, Newton PJ, Inglis S, Currow DC, Davidson PM. Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research. J Pain Symptom Manag. 2014;48:1182–99.

    Article  Google Scholar 

  64. Fox E, Landrum-McNiff K, Zhong Z, Dawson NV, Wu AW, Lynn J. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. JAMA. 1999;282:1638–45.

    Article  CAS  PubMed  Google Scholar 

  65. Healthcare V. Hospice eligibility: end-stage copd and other forms of lung disease. 2020 [cited 2020 December 1]. Available from: https://www.vitas.com/for-healthcare-professionals/hospice-and-palliative-care-eligibility-guidelines/hospice-eligibility-guidelines/copd-and-lung-disease.

  66. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320:469–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Noppe D, Veen HI, Mooren K. COPD patients in need of palliative care: identification after hospitalization through the surprise question. Chron Respir Dis. 2019;16:1479972318796219.

    Article  PubMed  Google Scholar 

  68. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–12.

    Article  CAS  PubMed  Google Scholar 

  69. Duenk RG, Verhagen C, Bronkhorst EM, Djamin RS, Bosman GJ, Lammers E, Dekhuijzen P, Vissers K, Engels Y, Heijdra Y. Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care. Int J Chron Obstruct Pulmon Dis. 2017;12:2121–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Rocker GM, Verma JY. 'INSPIRED' COPD Outreach Program: doing the right things right. Clin Invest Med. 2014;37:E311–9.

    Article  PubMed  Google Scholar 

  71. Blackman R, Demmons J, Gillis D, Rocker G. Dying at home from COPD: feasible or fantasy. Chest. 2016;150:951A.

    Article  Google Scholar 

  72. Scheerens C, Chambaere K, Pardon K, Derom E, Van Belle S, Joos G, Pype P, Deliens L. Development of a complex intervention for early integration of palliative home care into standard care for end-stage COPD patients: a phase 0-I study. PLoS One. 2018;13:e0203326.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Scheerens C, Pype P, Van Cauwenberg J, Vanbutsele G, Eecloo K, Derom E, Van Belle S, Joos G, Deliens L, Chambaere K. Early-integrated palliative home care and standard care for end-stage COPD (EPIC): a phase II pilot RCT testing feasibility, acceptability and effectiveness. J Pain Symptom Manag. 2019;

    Google Scholar 

  74. Reilly CC, Bausewein C, Pannell C, Moxham J, Jolley CJ, Higginson IJ. Patients' experiences of a new integrated breathlessness support service for patients with refractory breathlessness: results of a postal survey. Palliat Med. 2016;30:313–22.

    Article  PubMed  Google Scholar 

  75. Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, McCrone P, Booth S, Jolley CJ, Moxham J. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2:979–87.

    Article  PubMed  Google Scholar 

  76. Smallwood N, Thompson M, Warrender-Sparkes M, Eastman P, Le B, Irving L, Philip J. Integrated respiratory and palliative care may improve outcomes in advanced lung disease. ERJ Open Res. 2018;4

    Google Scholar 

  77. Ward H. Improving access and coordination to palliative care for patients with end stage respiratory disease – The Royal Wolverhampton NHS Trust and Compton Care. 2020 [cited 2020 December 1]. Available from: https://www.england.nhs.uk/ourwork/clinical-policy/respiratory-disease/improving-access-and-coordination-to-palliative-care/.

  78. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP, Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Sante du Q. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163:585–91.

    Article  PubMed  Google Scholar 

  79. Janssen DJ, McCormick JR. Palliative care and pulmonary rehabilitation. Clin Chest Med. 2014;35:411–21.

    Article  PubMed  Google Scholar 

  80. Dransfield MT, Garner JL, Bhatt SP, Slebos DJ, Klooster K, Sciurba FC, Shah PL, Marchetti NT, Sue RD, Wright S, Rivas-Perez H, Wiese TA, Wahidi MM, Goulart de Oliveira H, Armstrong B, Radhakrishnan S, Shargill NS, Criner GJ, Group LS. Effect of Zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year. Results from a randomized clinical trial. Ann Am Thorac Soc. 2020;17:829–38.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Kamal AH, Wolf SP, Troy J, Leff V, Dahlin C, Rotella JD, Handzo G, Rodgers PE, Myers ER. Policy changes key to promoting sustainability and growth of the specialty palliative care workforce. Health Aff. 2019;38:910–8.

    Article  Google Scholar 

  82. Gardener AC, Ewing G, Mendonca S, Farquhar M. Support needs approach for patients (SNAP) tool: a validation study. BMJ Open. 2019;9:e032028.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Grudzen CR, Brody AA, Chung FR, Cuthel AM, Mann D, McQuilkin JA, Rubin AL, Swartz J, Tan A, Goldfeld KS, Investigators P-E. Primary palliative care for emergency medicine (PRIM-ER): Protocol for a pragmatic, cluster-randomised, stepped wedge design to test the effectiveness of primary palliative care education, training and technical support for emergency medicine. BMJ Open. 2019;9:e030099.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Pelayo-Alvarez M, Perez-Hoyos S, Agra-Varela Y. Clinical effectiveness of online training in palliative care of primary care physicians. J Palliat Med. 2013;16:1188–96.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O'Donnell DE, Maltais F, Mularski RA, Cave AJ, Mayers I, Kennedy V, Oliver TK, Brown C, Canadian Thoracic Society CCDEWG. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18:69–78.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008. CD005623.

    Google Scholar 

  87. Mularski RA, Reinke LF, Carrieri-Kohlman V, Fischer MD, Campbell ML, Rocker G, Schneidman A, Jacobs SS, Arnold R, Benditt JO, Booth S, Byock I, Chan GK, Curtis JR, Donesky D, Hansen-Flaschen J, Heffner J, Klein R, Limberg TM, Manning HL, Morrison RS, Ries AL, Schmidt GA, Selecky PA, Truog RD, Wang AC, White DB, Crisis ATSAHCoPMoD. An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis. Ann Am Thorac Soc. 2013;10:S98–106.

    Article  PubMed  Google Scholar 

  88. Swan F, Newey A, Bland M, Allgar V, Booth S, Bausewein C, Yorke J, Johnson M. Airflow relieves chronic breathlessness in people with advanced disease: an exploratory systematic review and meta-analyses. Palliat Med. 2019;33:618–33.

    Article  PubMed  Google Scholar 

  89. Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3:CD011008.

    PubMed  Google Scholar 

  90. Verberkt CA, van den Beuken-van Everdingen MHJ, Schols J, Datla S, Dirksen CD, Johnson MJ, van Kuijk SMJ, Wouters EFM, Janssen DJA. Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain? Eur Respir J. 2018;52:1800882.

    Article  PubMed  CAS  Google Scholar 

  91. Verberkt CA, van den Beuken-van Everdingen MHJ, Schols J, Hameleers N, Wouters EFM, Janssen DJA. Effect of sustained-release morphine for refractory breathlessness in chronic obstructive pulmonary disease on health status: a randomized clinical trial. JAMA Intern Med. 2020;180:1306–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Ekstrom MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014;348:g445.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  93. Chamberlain Mitchell SA, Garrod R, Clark L, Douiri A, Parker SM, Ellis J, Fowler SJ, Ludlow S, Hull JH, Chung KF, Lee KK, Bellas H, Pandyan A, Birring SS. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax. 2017;72:129–36.

    Article  PubMed  Google Scholar 

  94. Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest. 2016;149:639–48.

    Article  PubMed  Google Scholar 

  95. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380:1583–9.

    Article  CAS  PubMed  Google Scholar 

  96. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA. Anxiety AWPo, depression in C. anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134:43S–56S.

    Article  PubMed  Google Scholar 

  97. Pollok J, van Agteren JE, Carson-Chahhoud KV. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;12:CD012346.

    PubMed  Google Scholar 

  98. Pollok J, van Agteren JE, Esterman AJ, Carson-Chahhoud KV. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019;3:CD012347.

    PubMed  Google Scholar 

  99. Gordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156:80–91.

    Article  PubMed  Google Scholar 

  100. Meehan E, Sweeney C, Foley T, Lehane E, Burgess Kelleher A, Hally RM, Shanagher D, Korn B, Rabbitte M, Detering KM, Cornally N. Advance care planning in COPD: guidance development for healthcare professionals. BMJ Support Palliat Care. 2019.

    Google Scholar 

  101. Carpentieri JD, Elliott J, Brett CE, Deary IJ. Adapting to aging: older people talk about their use of selection, optimization, and compensation to maximize Well-being in the context of physical decline. J Gerontol B Psychol Sci Soc Sci. 2017;72:351–61.

    CAS  PubMed  Google Scholar 

  102. Enguidanos SM, Cherin D, Brumley R. Home-based palliative care study: site of death, and costs of medical care for patients with congestive heart failure, chronic obstructive pulmonary disease, and cancer. J Soc Work End Life Palliat Care. 2005;1:37–56.

    Article  PubMed  Google Scholar 

  103. Tinelli M, Kanavos P, Efthymiadou O, Visintin E, Grimaccia F, Mossman J. Using IMPRESS to guide policy change in multiple sclerosis. Mult Scler. 2018;24:1251–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anand S. Iyer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Iyer, A.S., Khateeb, D. (2021). Palliative Care in COPD. In: Lindell, K.O., Danoff, S.K. (eds) Palliative Care in Lung Disease. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-81788-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81788-6_10

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-81787-9

  • Online ISBN: 978-3-030-81788-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics